As of February 2026 Neurocrine Biosciences has a market cap of A$20.05 Billion. This makes Neurocrine Biosciences the world's 1550th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 6th, 2026 the market cap of Neurocrine Biosciences was reported to be: